Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.04
+0.48 (5.02%)
At close: Jul 2, 2026, 4:00 PM EDT
9.85
-0.19 (-1.89%)
After-hours: Jul 2, 2026, 5:09 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.69 billion as of July 2, 2026. Its market cap has increased by 140.17% in one year.
Market Cap
1.69B
Enterprise Value
1.31B
1-Year Change
140.17%
Ranking
Category
Stock Price
$10.04
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.69B, an increase of 10.40%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 1.69B | 101.84% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.72B |
| Zenas BioPharma | 1.72B |
| Aktis Oncology | 1.71B |
| MapLight Therapeutics | 1.68B |
| Immunocore Holdings | 1.65B |
| Innoviva | 1.64B |
| Ascentage Pharma Group International | 1.64B |
| Fortrea Holdings | 1.63B |